COLOMBO, MASSIMO GIUSEPPE
COLOMBO, MASSIMO GIUSEPPE
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy
2021 V. Burgio, M. Iavarone, G.G. Di Costanzo, F. Marra, S. Lonardi, E. Tamburini, F. Piscaglia, G. Masi, C. Celsa, F.G. Foschi, M. Silletta, D.C. Amoruso, M. Rimini, M. Bruccoleri, R. Tortora, C. Campani, C. Solda, M.G. Viola, A. Forgione, F. Conti, F. Salani, S. Catanese, C.M. Giacchetto, C. Fulgenzi, C. Coppola, P. Lampertico, A. Pellino, G. Rancatore, G. Cabibbo, F. Ratti, F. Pedica, A. Della Corte, M. Colombo, F. De Cobelli, L. Aldrighetti, S. Cascinu, A. Casadei-Gardini
Digitization in the Market for Entrepreneurial Finance: Innovative Business Models and New Financing Channels
2021 F. Bertoni, S. Bonini, V. Capizzi, M.G. Colombo, S. Manigart
Feasibility and reproducibility of liver and pancreatic stiffness in patients with alcohol-related liver disease
2019 C.B. Conti, N. Weiler, G. Casazza, C. Schrecker, M. Schneider, M.M. Mücke, A. Queck, E. Herrmann, D. Conte, M. Colombo, S. Zeuzem, M. Fraquelli, M. Friedrich-Rust
Harmful and Beneficial Effects of Anti-coagulants in Patients With Cirrhosis and Portal Vein Thrombosis
2018 V. La Mura, S.V.M. Braham, G. Tosetti, F. Branchi, N. Bitto, M. Moia, A.L. Fracanzani, M. Colombo, A. Tripodi, M. Primignani
Multimodality treatment of hepatocellular carcinoma : How field practice complies with international recommendations
2018 A. Sangiovanni, M. Triolo, M. Iavarone, L.V. Forzenigo, A. Nicolini, G. Rossi, V. La Mura, M. Colombo, P. Lampertico
IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients
2018 E. Galmozzi, F. Facchetti, G. Glenda, A. Loglio, M. Vigano', L. Giovanna, M.G. Colombo, P. Lampertico
Management of Biliary Anastomotic Strictures After Liver Transplantation (BASALT Study): a Nationwide Italian Survey
2017 P. Cantù, I. Parzanese, V. Balassone, A. Di Sario, F. Soggiu, G. Lombardi, F. Barbaro, A. Pisani, A. Baldan, G. Cariani, V. Boarino, A. Fasoli, H. Bertani, E. Forti, M. Bulajic, D. Ghinolfi, E. Nadal, A. Cerofolini, L. Barresi, G. Catalano, I. Stroppa, S. Traini, V. Mazzaferro, L. Cipolletta, A. Tringali, G. Costamagna, P. Ravelli, F. Bazzoli, A. Merighi, M. Caterina Parodi, R. Conigliaro, M. Mutignani, M. Zilli, F. Filipponi, A. Fantin, L. Rodella, I. Tarantino, M. Traina, M. Salizzoni, R. Rosa, F. Malinverno, F. Invernizzi, M. Manini, M.F. Donato, M. Colombo, D. Conte, G. Rossi, R. Penagini
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
2017 P. George V., I. Ramazan, D. George N., B. Maria, C. Heng, V.B. Florian, C. Jose Luis, S. Vana, G. John, M. Spilios, A. Loglio, S. Spyros, K. Onur, G. Nikolaos, H. Bettina E., L. Maria, D.L.R. Juan, S. Savvoula, K. Anastasia, V. Ioannis, G. Kostantinos, Y. Cihan, B. Thomas, M.G. Colombo, E. Rafael, J. Harry L. A., P. Lampertico
Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection
2016 E. Degasperi, F. Caprioli, O. El Sherif, D. Back, M. Colombo, A. Aghemo
Deciding on interferon-free treatment for chronic hepatitis C : Updating liver stiffness cut-off values to maximize benefit
2016 A. Colli, M. Fraquelli, D. Prati, A. Riva, A. Berzuini, D. Conte, A. Aghemo, M. Colombo, G. Casazza
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
2016 G. Papatheodoridis, G. Dalekos, V. Sypsa, C. Yurdaydin, M. Buti, J. Goulis, J.L. Calleja, H. Chi, S. Manolakopoulos, G. Mangia, N. Gatselis, O. Keskin, S. Savvidou, J. De La Revilla, B.E. Hansen, I. Vlachogiannakos, K. Galanis, R. Idilman, M. Colombo, R. Esteban, H.L.A. Janssen, P. Lampertico
Liver stiffness measurement reliability and main determinants of point shear-wave elastography in patients with chronic liver disease
2016 M. Fraquelli, A. Baccarin, G. Casazza, C.B. Conti, M. Giunta, S. Massironi, F. Invernizzi, M.F. Donato, M. Maggioni, A. Aghemo, D. Conte, M. Colombo
Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib
2016 M. Iavarone, M. Primignani, S. Vavassori, A. Sangiovanni, V. La Mura, R. Romeo, M. Colombo
Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis
2016 V. La Mura, A. Tripodi, G. Tosetti, F. Cavallaro, V. Chantarangkul, M. Colombo, M. Primignani
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection
2016 M.A. Burza, B.M. Motta, R.M. Mancina, P. Pingitore, C. Pirazzi, S.M. Lepore, R. Spagnuolo, P. Doldo, C. Russo, V. Lazzaro, J. Fischer, T. Berg, A. Aghemo, C. Cheroni, R. De Francesco, S. Fargion, M. Colombo, C. Datz, F. Stickel, L. Valenti, S. Romeo
Serological tests do not predict residual fibrosis in hepatitis C cirrhotics with a sustained virological response to interferon
2016 R. D'Ambrosio, E. Degasperi, A. Aghemo, M. Fraquelli, P. Lampertico, M.G. Rumi, F. Facchetti, E. Grassi, G. Casazza, W. Rosenberg, P. Bedossa, M. Colombo
The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices : a 12-year prospective cohort study
2015 P. Lampertico, F. Invernizzi, M. Vigano', A. Loglio, G. Mangia, F. Facchetti, M. Primignani, M. Jovani, M.A. Iavarone, M. Fraquelli, G. Casazza, R. DE FRANCHIS, M.G. Colombo
Refining sorafenib therapy : lessons from clinical practice
2015 L. Bolondi, A. Craxi, F. Trevisani, B. Daniele, G.G. Di Costanzo, S. Fagiuoli, C. Cammà, P. Bruzzi, R. Danesi, F. Spandonaro, C. Boni, A. Santoro, M. Colombo
Will the benefits of treatment for chronic hepatitis C be retained in the interferon-free era?
2015 A. Aghemo, M. Colombo
Hepatocellular carcinoma in patients with a sustained response to anti-hepatitis C therapy
2015 R. D’Ambrosio, C. Della Corte, M. Colombo